ISRG vs STXS
ISRG: Intuitive Surgical is the dominant innovator and market leader in robotic-assisted surgical platforms, driving a shift toward minimally invasive clinical outcomes. STXS: Stereotaxis provides advanced robotic magnetic navigation systems that enhance the precision, safety, and efficiency of minimally invasive endovascular and electrophysiology procedures.
Side-by-side fundamentals
| Metric | ISRG | STXS | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $415.41 | $1.11 | |
| Market cap | $146.8B | $111M | |
| P/E as of 2026-10-08 | 47.61 | n/a | |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 1.63 | n/a | |
| Net margin FY2025, SEC XBRL | +28.4% | -66.8% | ISRG higher |
| Gross margin FY2025, SEC XBRL | +66.0% | +52.7% | ISRG higher |
| Operating margin FY2025, SEC XBRL | +29.3% | -68.3% | ISRG higher |
| ROE FY2025, SEC XBRL | +16.0% | -160.5% | ISRG higher |
| ROA FY2025, SEC XBRL | +14.0% | -41.4% | ISRG higher |
| Debt / equity as of 2026-09-02 | 0.00 | 0.00 | Tie |
| Revenue growth (YoY) as of 2026-09-02 | +20.7% | +13.4% | ISRG higher |
| Revenue CAGR (3y) SEC XBRL | +17.4% | +4.8% | ISRG higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-02 | 1.15 | 1.40 | |
| 1-year return as of 2026-10-08 close | -7.3% | -68.9% | ISRG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.